No Detail Found!

Electroconvulsive Therapy (ECT) for the Management of Neuroleptic Malignant Syndrome (NMS) in Adults.

Author(s)
Jahanzeb Liaqat Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Muhammad Umar Javed 123 Medical Battalion Skardu, Pakistan
Arshad Naseem Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Waseem Raja 144 Medical Battalion Goma Siachin, Pakistan
Waseem Wali Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Abstract
Objective: To determine the efficacy and safety of electroconvulsive therapy (ECT) for the management of neuroleptic malignant syndrome (NMS) in adults. Study Design: Open label, unblinded series. Place and Duration of Study: This study was carried out at the Department of Neurology, Military Hospital Rawalpindi, from Jan 2015 to Dec 2015. Material and Methods: All the patients with the diagnosis of NMS during the study period were included in the study. Consective non-probability sampling technique was used. Patients were divided into two groups; uncomplicated and complicated cases of NMS. Results: A total of nineteen patients were included in this pilot study. Out of all, thirteen (68.4%) were males and six (31.6%) were females. Mean age of the patients was 35.05 (SD 13.362) years. The drug classes causing NMS were antipsychotic medicines in 73.7% of patients and antiemetics in 26.3% of patients. Mean electroconvulsive therapy (ECT) sessions given were 6.16 (SD 2.062). Following treatment n=16 (84.2%) patients had complete recovery while n=3 (15.3%) patients died. Conclusion: In this small, open label, unblinded study ECT appears effective and safe in treating NMS in adults. Larger randomized studies will help to confirm data emerging from this preliminary study.
Publication Details
Page(s) 445-449
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 3, Year: 2018

Request the full text from PASTIC

References
OruchR,PrymeIF,EngelsenBA,LundA, 2017.Neuroleptic malignant syndrome: An easily overlooked neurologic emergency,Neuropsychiatr Dis Treat 13 161 -75
NagelM,FreisbergS,JunghannsK,MollCK,WillenborgB, 2015.Das maligne neuroleptische syndrome (NMS) - Eine systematische ϋbersicht,[The neuroleptic malignant syndrome] Fortschr Neurol Psychiatr 83 373 -80
GerlachM,RiedererP,SchellerD., 2011.Mechanisms underlying and medical management of L-Dopa-associated motor complications,J Neural Transm 118 1659 -60
CaroffSN,MannSC, 1993.Neuroleptic malignant syndrome,Med Clin North Am 77 185 -202
ShalevA,HermeshH,Muntiz H, 1989.Mortality from neuroleptic malignant syndrome,J Clin Psychiatry 50 18 -
Al DanafJ,MadaraJ,DietscheC, 2015.Neuroleptic malignant syndrome: A case aimed at raising clinical awareness,Case Rep Med 769576 -
ButwickaA,KrystynaS,RetkaW,WolanczykT., 2014.Neuroleptic malignant syndrome in an adolescent with CYP2D6 deficiency,Eur J Pediatr 173 1639 -42
SarkarP,NatarajanC,GodeN., 2009.Prevalence of neuroleptic malignant syndrome in 672 consecutive male in-patients,Indian J Psychiatry 51 202 -05
ChenPH,LaneHY,LinCH, 2016.Venous thromboembolism following dantrolene treatment for neuroleptic malignant syndrome,Clin Psychopharmacol Neurosci 14 399 -401
DavisJM,JanicakPG,SakkasP., 1991.Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome,Convuls Ther 7 111 -
ScheftnerWA,ShulmanRB, 1992.Treatment choice in neuroleptic malignant syndrome,Convuls Ther 8 267 -79
TrollorJN,SachdevPS,Z J, 1999.Electroconvulsive treatment of neuroleptic malignant syndrome: A review and report of cases, 33 650 -9
BuggenhoutS,VandenbergheJ,SienaertP., 2014.Electroconvulsion therapy for neuroleptic malignant syndrome,Tijdschr Psychiatr 56 612 -5
0

Citations

0

Downloads

66

Views